Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
BPC-157 research published in Current Pharmaceutical Design demonstrated accelerated tendon-to-bone healing in rat models, with treated groups showing 40% greater tensile strength at 4-week follow-up compared to controls
As of April 2026, BPC-157 is on the FDA's 503A Category 2 list
Understanding the consequences of storage errors helps patients make informed decisions about medication safety
DOI: 10.1038/sj.jp.7211334 [ Links ] Crill CM, Storm MC, Christensen ML, Hankins CT, Jenkins MB, Helms RA
US$ 27.26
US$ 28.72
US$ 29.81
